Announcements Trials
Browse Landscape

Phase

Phase NA 20Phase EARLY_PHASE1 4Phase 1 4Phase 2 3Phase 1/2 1

Status

Completed 10Recruiting 7Terminated 4Active not recruiting 4Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 1

Conditions

Sarcoma 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 98pembrolizumab 85Gemcitabine 81Carboplatin 62fludarabine 61Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 49Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 33Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26Pemetrexed 25atezolizumab 24Oxaliplatin 24Capecitabine 24fludarabine phosphate 22Filgrastim 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Blood Specimen Collection × Clear all
NCT04037527 2026-02-04

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Wake Forest University Health Sciences

Phase 1 Terminated
9 enrolled
Sarcoma

Sarcoma

NCT03275974 2026-01-02

Glutamine PET Imaging Colorectal Cancer

M.D. Anderson Cancer Center

Phase 1 Terminated
6 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03956056 2024-07-17

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Washington University School of Medicine

Phase 1 Terminated
12 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01521780 2015-11-02

Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)

Merck Sharp & Dohme LLC

Phase 1 Terminated
12 enrolled 7 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡